07 Jan 2001

Becozyme c - España

Updated: 07 Jan 2001

Becozyme c forte 30 grageas

Profilaxis de estados carenciales de vitaminas del grupo B y vitamina C: Restricciones dietéticas, malabsorción, tratamiento.

Becozyme c Description, Presentation and Dosage

Becozyme c Description

Becozyme c Drug Class Description

Complejo b, otras asociaciones

Becozyme c Drug Description


Becozyme c Presentation

Becozyme c Presentation

Dosis usual: 1-3 grageas al día.

Becozyme c Manufacturer


Related Learning Zones

Anti-Infectives Knowledge Network CDI

Anti-Infectives Knowledge Network CDI

The Anti-Infectives Knowledge Network – Clostridium difficile infection (AIKN-CDI), an initiative by Astellas Pharma EMEA, shares the expertise and experience of thought leaders in the therapy area of anti-infectives, with a particular focus on C. difficile infection.

Recent updates include ECCMID, ICDS, EBMT and ISICEM 2015 slide decks and congress reports, an infographic on ‘CDI in the EU’, data from the largest ever European clinician consensus report, as well as congress overviews, news reports and CDI expert perspectives.

Anti-Infectives Knowledge Network IFI

Anti-Infectives Knowledge Network IFI

The Anti-Infectives Knowledge Network – Invasive Fungal Infections (AIKN-IFI), an initiative by Astellas Pharma EMEA, assembles the experience and expertise of a number of thought leaders in the area of anti-infectives, with a particular focus on invasive fungal infections.

This free resource is regularly updated with congress highlights, industry reports, policy changes, clinical guidelines and downloadable material from major medical events, so make sure you return often.

August 2015 MYC/15/0023/EUa

Becozyme c Dosage

Becozyme c Precautions, Reactions and Contraindications

Becozyme c Special Precautions

Related Drugs - Gastroenterologia

Back to top